Lastly, C-reactive protein and TIMP-1 levels were augmented AD patients, and they declined amazingly after acetylcholinesterase inhibitor therapy, which is among the limited existing treatment of AD [141]. This evidence concerns the gene CRP and Alzheimer disease.